Market Access News | pharmaphorum

News

AZ's antibody first to be cleared by FDA for COVID preventio...

AstraZeneca's antibody cocktail for COVID-19, now called Evusheld, has become the first drug in the class to be authorised for prevention of infection by the US FDA.

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

FDA advisors unconvinced by Reata's kidney disease drug

An FDA advisory committee has delivered a blow to Reata Pharma, after voting unanimously that the drugmaker's data on bardoxolone – a drug for kidney disease – did not show it is effective.

News

EU approves Roche's Actemra for severe COVID-19

The European Commission has moved swiftly to grant full approval to Roche's Actemra/RoActemra as a treatment for severe COVID-19, clearing the drug within 24 hours of a recommendation from

Market Access

scientifically visualization of a coronavirus spike protein

MHRA okays GSK's Xevudy as data suggest it works against Omi...

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech's antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in

News

Merck's oral COVID drug squeaks past FDA advisory committee

An FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Ridgeback's oral antiviral molnupiravir for mild-to-moderate COVID-19, saying it

News

FDA sets Sept review date for BMS' psoriasis drug deucravaci...

The FDA has kicked off its review of Bristol-Myers Squibb's psoriasis therapy deucravacitinib, setting an action date of 1 September next year, as the EU and Japanese regulators also start

AZ's antibody first to be cleared by FDA for COVID preventio...

FDA advisors unconvinced by Reata's kidney disease drug

EU approves Roche's Actemra for severe COVID-19

MHRA okays GSK's Xevudy as data suggest it works against Omi...

Merck's oral COVID drug squeaks past FDA advisory committee

FDA sets Sept review date for BMS' psoriasis drug deucravaci...

FDA starts review of Regeneron's drug for rare disease FOP

How to meet your physicians where they are online

News

Editor's Picks